Levodopa/Benserazide Teva Uk

Levodopa, the active ingredient in Levodopa/Benserazide Teva Uk, is an Antiparkinson agent presented as an oral tablet for oral use. It treats Parkinson's disease by restoring dopamine levels in patients with the condition.

GNH USA supplies Levodopa/Benserazide Teva Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Benserazide is an antiparkinson medication used to manage motor symptoms in Parkinsonian disorders.

- Parkinson's disease: improves rigidity, bradykinesia and tremor by increasing central dopamine. - Levodopa‑responsive Parkinsonism: provides symptomatic relief in patients with fluctuating response to therapy. - Early‑stage Parkinson's disease: may delay the onset of motor complications when used as initial treatment.

Levodopa/Benserazide may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Orthostatic hypotension: dizziness upon standing. - Headache: transient cranial discomfort. - Insomnia: difficulty initiating sleep. - Dyspepsia: indigestion or abdominal discomfort. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations or psychosis: visual or auditory disturbances. - Severe hypotension: marked blood pressure drop requiring medical attention. - Cardiac arrhythmias: irregular heart rhythms. - Neuroleptic malignant syndrome: rare but life‑threatening reaction.

When prescribing Levodopa/Benserazide, clinicians should consider several safety measures.

- Monitor blood pressure: watch for orthostatic hypotension, especially during dose titration. - Assess renal function: adjust therapy if significant impairment is present. - Screen psychiatric history: patients with prior psychosis may be at higher risk of hallucinations. - Avoid abrupt discontinuation: sudden stop can worsen Parkinsonian symptoms. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Levodopa/Benserazide can interact with several medication classes.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: may precipitate hypertensive crisis. - Anticholinergic agents: can diminish antiparkinson efficacy. - High‑protein meals: compete for intestinal transport, reducing levodopa absorption.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: additive blood‑pressure‑lowering effect. - SSRIs or SNRIs: rare risk of serotonin syndrome. - Iron or calcium supplements: may decrease levodopa bioavailability when taken concurrently.